OFIX Orthofix Medical Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: OFIX

Price (delayed)

$10.01

Market cap

$407.73M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.53

Enterprise value

$537.95M

?
Relative Growth: Rel. Growth: 50
Relative Strength: Rel. Strength: 15
Relative Valuation: Rel. Valuation: 39
Relative Profitability: Rel. Profitability: 42

Orthofix is a global medical technology company headquartered in Lewisville, Texas. By providing medical technologies that heal musculoskeletal pathologies, Orthofix delivers exceptional experiences and life-changing solutions to patients around the ...

Highlights
The gross profit has increased by 9% year-on-year
Orthofix Medical's gross margin has increased by 6% YoY
The EPS has soared by 52% YoY but it has contracted by 2% from the previous quarter
The net income has soared by 50% YoY but it has contracted by 2.9% from the previous quarter
Orthofix Medical's debt has increased by 34% YoY
The equity has contracted by 6% YoY
Sector: Healthcare
Industry: Medical Devices
Website: http://www.orthofix.com
Peers: ATEC SYK GMED

Key stats

What are the main financial stats of OFIX

OFIX stock price

How has the Orthofix Medical stock price performed over time
Intraday
0%
1 week
-3.19%
1 month
-13.93%
1 year
-31.2%
YTD
-33.97%
QTD
9.52%

Financial performance

How have Orthofix Medical's revenue and profit performed over time
Revenue
$833.19M
Gross profit
$594.12M
Operating income
-$39.12M
Net income
-$61.72M
Gross margin
71.3%
Net margin
-7.4%
The company's operating margin has surged by 60% YoY and by 18% QoQ
The company's operating income has surged by 59% YoY and by 17% QoQ
Orthofix Medical's net margin has soared by 52% YoY
The net income has soared by 50% YoY but it has contracted by 2.9% from the previous quarter

Price vs fundamentals

How does OFIX's price correlate with its fundamentals

Growth

What is Orthofix Medical's growth rate over time

Valuation

What is Orthofix Medical stock price valuation
P/E
N/A
P/B
0.94
P/S
0.49
EV/EBIT
N/A
EV/EBITDA
40.51
EV/Sales
0.65
The EPS has soared by 52% YoY but it has contracted by 2% from the previous quarter
The stock's price to book (P/B) is 22% less than its 5-year quarterly average of 1.2 and 15% less than its last 4 quarters average of 1.1
The equity has contracted by 6% YoY
The price to sales (P/S) is 46% lower than the 5-year quarterly average of 0.9 and 18% lower than the last 4 quarters average of 0.6
The revenue is up by 3% year-on-year

Efficiency

How efficient is Orthofix Medical business performance
The ROIC has soared by 60% YoY and by 5% from the previous quarter
The ROS has soared by 59% YoY and by 6% from the previous quarter
OFIX's return on assets has surged by 50% year-on-year but it is down by 2.9% since the previous quarter
OFIX's ROE is up by 44% YoY but it is down by 5% QoQ

Dividends

What is OFIX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for OFIX.

Financial health

How did Orthofix Medical financials performed over time
The total assets is 97% greater than the total liabilities
The company's total liabilities rose by 17% YoY
Orthofix Medical's quick ratio has increased by 14% YoY but it has decreased by 5% QoQ
Orthofix Medical's debt is 45% less than its equity
OFIX's debt to equity is up by 45% YoY
Orthofix Medical's debt has increased by 34% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.